CuriosityStream Inc. (CURI)

Price$2.72Cached quote
CURINasdaq
Loading local price history

Financial charts

Revenue

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022202120202019
Revenue$71.7M$51.1M$56.9M$78.0M$3.0M$39.6M$18.0M
Gross profit$40.5M$25.8M$21.3M$26.5M$1.8M——
Gross margin56.58%50.40%37.50%33.96%59.93%——
Operating expenses$79.0M$64.5M$101.4M$133.3M$123.7M$78.4M$62.6M
Operating income−$7.3M−$13.3M−$44.5M−$55.3M−$52.5M−$38.8M−$44.6M
Operating margin−10.19%−26.07%−78.17%−70.84%−1,749.30%−97.93%−247.39%
EBITDA−$7.1M−$13.0M−$44.0M−$54.6M−$51.9M−$38.4M−$44.5M
EBITDA margin−9.96%−25.41%−77.30%−69.94%−1,728.90%−96.94%−246.60%
Net income−$6.4M−$12.9M−$48.9M−$50.9M−$37.6M−$48.6M−$42.7M
Net profit margin−8.97%−25.31%−85.95%−65.24%−1,254.50%−122.66%−236.69%
Basic EPSper basic share-$0.11-$0.24-$0.92-$0.96-$0.73-$3.30-$4.45
Diluted EPSper diluted share-$0.11-$0.24-$0.92-$0.96-$1.02-$3.30-$4.45

Owners

Reported shareholders

Reference date Jun 30, 2026
HENDRICKS JOHN S · ≈21.32% of listed sharesStinchcomb Clinton Larry · ≈5.03% of listed sharesBlackRock, Inc. · 4.66% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 2.86% of listed sharesTHOMPSON SIEGEL & WALMSLEY LLC · 2.83% of listed sharesRENAISSANCE TECHNOLOGIES LLC · 2.59% of listed sharesHUBERMAN JONATHAN · ≈2.37% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 1.78% of listed sharesLOS ANGELES CAPITAL MANAGEMENT LLC · 1.65% of listed sharesGOLDMAN SACHS GROUP INC · 1.64% of listed sharesPenbrook Management LLC · 1.29% of listed sharesSTATE STREET CORP · 1.15% of listed sharesESSEX INVESTMENT MANAGEMENT CO LLC · 1.01% of listed sharesCudahy Theresa Ellen · ≈0.86% of listed sharesBank of New York Mellon Corp · 0.75% of listed sharesNORTHERN TRUST CORP · 0.73% of listed sharesUBS Group AG · 0.67% of listed sharesVANGUARD PORTFOLIO MANAGEMENT LLC · 0.61% of listed sharesJACOBS LEVY EQUITY MANAGEMENT, INC · 0.50% of listed sharesMILLENNIUM MANAGEMENT LLC · 0.47% of listed shares
≈21.32%of listed shares
HENDRICKS JOHN S12.6M shares · Aug 14, 2025
View holders
Top 20 reported holders of CURI
Holder% owned
HENDRICKS JOHN S
≈21.32%12.6M shares
Stinchcomb Clinton Larry
≈5.03%2.97M shares
BlackRock, Inc.
4.66%2.76M shares
VANGUARD CAPITAL MANAGEMENT LLC
2.86%1.69M shares
THOMPSON SIEGEL & WALMSLEY LLC
2.83%1.67M shares
RENAISSANCE TECHNOLOGIES LLC
2.59%1.53M shares
HUBERMAN JONATHAN
≈2.37%1.4M shares
GEODE CAPITAL MANAGEMENT, LLC
1.78%1.05M shares
LOS ANGELES CAPITAL MANAGEMENT LLC
1.65%976.58K shares
GOLDMAN SACHS GROUP INC
1.64%967.87K shares
Penbrook Management LLC
1.29%764.8K shares
STATE STREET CORP
1.15%678.57K shares
ESSEX INVESTMENT MANAGEMENT CO LLC
1.01%595.06K shares
Cudahy Theresa Ellen
≈0.86%508.88K shares
Bank of New York Mellon Corp
0.75%445.17K shares
NORTHERN TRUST CORP
0.73%430.85K shares
UBS Group AG
0.67%394.37K shares
VANGUARD PORTFOLIO MANAGEMENT LLC
0.61%362.48K shares
JACOBS LEVY EQUITY MANAGEMENT, INC
0.50%293.34K shares
MILLENNIUM MANAGEMENT LLC
0.47%280.62K shares

Percentages use 59.11M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys8$449.4K disclosed value
Sells (SEC code S)58$36.73M disclosed value
66 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 12, 2026Form 4Hayden Phillip BradyChief Financial OfficerSellCommon Stock · indirect30.4K$2.56$77.8K71.3K
Jun 12, 2026Form 4Keeley Patrick J.DirectorSellCommon Stock31.6K$2.70$85.2K188.4K
May 28, 2026Form 4Stinchcomb Clinton LarryPresident and CEOBuyCommon Stock25.7K$2.78$71.6K2.97M
May 27, 2026Form 4Stinchcomb Clinton LarryPresident and CEOBuyCommon Stock94.3K$2.74$258.3K2.95M
May 26, 2026Form 4Stinchcomb Clinton LarryPresident and CEOBuyCommon Stock30.0K$2.67$80.1K2.85M

Community posts

It’s quiet here.

No posts about CURI yet. Start the conversation.

Write the first post